立法机关
工作(物理)
政治学
医学
法学
公共行政
工程类
机械工程
作者
Gianpiero D’Antonio,Giorgio Bolino,Letizia Sorace,Gianpietro Volonnino,Lavinia Pellegrini,Nicola Di Fazio,Paola Frati
出处
期刊:Healthcare
[MDPI AG]
日期:2024-08-21
卷期号:12 (16): 1665-1665
标识
DOI:10.3390/healthcare12161665
摘要
Despite the increasing efficacy of modern medicine in diagnosing and treating cancer, survivors often face discrimination in employment, economics, insurance, and society. Law no. 193/2023, also known as the “Oncological Oblivion Law”, aims to provide an initial legislative response to discrimination against cancer survivors in Italy. After defining oncological oblivion in Article 1, the Law provides, in Articles 2, 3, and 4, directives to prevent discrimination against cancer survivors in the area of access to banking and insurance services, adoption procedures and access to or retention in employment. The aim of this work is to illustrate the content and the critical aspects of the recent Law 193/2023 in the landscape of European directives. The legislative process at the Chamber of Deputies and the Senate of the Italian Republic has been retraced through the consultation of preparatory works and bills registered on institutional databases. Law 193/2023 represents the first initiative in Italy aimed at the recognition of the right to oncological oblivion, not only in access to banking and insurance services as in other countries, but also in adoption, employment, and re-employment. Our opinion piece highlights the need for further clarification and expansion to prevent discrimination and protect the social–work–relational rights of people who have been affected by oncological diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI